These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 11703474
21. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Derry CJ, Derry S, Moore RA. Cochrane Database Syst Rev; 2012 Feb 15; 2012(2):CD008615. PubMed ID: 22336849 [Abstract] [Full Text] [Related]
23. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan. Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J. Headache; 2017 Jun 15; 57(6):862-876. PubMed ID: 28497569 [Abstract] [Full Text] [Related]
24. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Landy S, Savani N, Shackelford S, Loftus J, Jones M. Int J Clin Pract; 2004 Oct 15; 58(10):913-9. PubMed ID: 15587768 [Abstract] [Full Text] [Related]
25. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ. Neurology; 2003 Feb 25; 60(4):630-3. PubMed ID: 12601104 [Abstract] [Full Text] [Related]
26. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Schulman EA, Cady RK, Henry D, Batenhorst AS, Putnam DG, Watson CB, O'Quinn SO. Mayo Clin Proc; 2000 Aug 25; 75(8):782-9. PubMed ID: 10943230 [Abstract] [Full Text] [Related]
27. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Winner P, Ricalde O, Le Force B, Saper J, Margul B. Arch Neurol; 1996 Feb 25; 53(2):180-4. PubMed ID: 8639069 [Abstract] [Full Text] [Related]
28. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Géraud G, Spierings EL, Keywood C. Headache; 2002 Apr 25; 42 Suppl 2():S93-9. PubMed ID: 12028325 [Abstract] [Full Text] [Related]
29. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L, Rizatriptan Protocol 060 Study Group. Headache; 2001 Sep 25; 41(8):745-53. PubMed ID: 11576197 [Abstract] [Full Text] [Related]
30. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D. Clin Ther; 2004 Feb 25; 26(2):214-23. PubMed ID: 15038944 [Abstract] [Full Text] [Related]
32. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Neurology; 2004 Mar 23; 62(6):883-7. PubMed ID: 15037686 [Abstract] [Full Text] [Related]
33. Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses. Salonen R, Saiers J. Cephalalgia; 1999 Jan 23; 19(1):16-9. PubMed ID: 10099854 [Abstract] [Full Text] [Related]
34. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F. Headache; 2003 Sep 23; 43(8):835-44. PubMed ID: 12940804 [Abstract] [Full Text] [Related]
37. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Tørring J. Clin Ther; 2000 Aug 23; 22(8):981-9. PubMed ID: 10972634 [Abstract] [Full Text] [Related]
38. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V. Cephalalgia; 1999 Sep 23; 19(7):676-83; discussion 626. PubMed ID: 10524662 [Abstract] [Full Text] [Related]
39. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Headache; 2005 Sep 23; 45(8):983-91. PubMed ID: 16109111 [Abstract] [Full Text] [Related]
40. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study. Carpay HA, Matthijsse P, Steinbuch M, Mulder PG. Cephalalgia; 1997 Aug 23; 17(5):591-5. PubMed ID: 9251875 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]